-87%

est. 2Y upside i

HealthcareSeries C

NexHealth streamlines healthcare practice operations by connecting every step of the patient journey—from scheduling to payments—directly with health record systems.

Rank

#3666

Sector

HealthTech

Est. Liquidity

~2Y

Data Quality

Data: Low

The equity upside for a job candidate at NexHealth is significantly negative based on the stale $1B valuation from 2022.

Last updated: July 21, 2026

Bull (20%)-66%

Revenue projected at $68M; exit multiple sustained at 8x yields exit $544M, well below $1B entry; IPO catalyst could lift multiple but still negative return.

Base (40%)-86%

Revenue $68M, 5x multiple yields $340M exit; stale $1B valuation implies severe downside; common stock recovery after preference is minimal.

Bear (40%)-100%

Revenue $68M, 3x multiple yields $204M exit barely above $197M preference; common stock nearly wiped out.

Est. time to liquidity~2.0 years

Preference Stack Risk

high

Funding Intensity

20%

Total funding of $197.2M represents 19.7% of the $1B valuation, giving preferred holders significant liquidation preference.

Dilution Risk

high

With last round in 2022 and $197M total funding, a future raise may dilute common equity by 15-25%.

Secondary Liquidity

none

No secondary transactions detected; liquidity likely only through IPO or acquisition.

Other — 42 roles

View all 42 open roles at NexHealth →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on NexHealth's data — designed to show you've done your homework.

  • 1

    “How does NexHealth plan to defend against free tools from Zocdoc?”

  • 2

    “What is the path to profitability and how does it affect future fundraising?”

  • 3

    “Given the stale valuation, what is your personal view on the current fair value of equity?”

Community

Valuation Sentiment

Our model estimates -87% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.